{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:44:54Z","timestamp":1792143894231,"version":"4.4.0"},"publisher-location":"New York, NY","reference-count":49,"publisher":"Springer US","isbn-type":[{"value":"9781071655863","type":"print"},{"value":"9781071655870","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5587-0_5","type":"book-chapter","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:54:33Z","timestamp":1792140873000},"page":"79-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["(Immuno-)Histological Analysis of Ewing Sarcoma"],"prefix":"10.1007","author":[{"given":"David","family":"Marcilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G. P.","family":"Gr\u00fcnewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Civantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Llombart-Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"de \u00c1lava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"5_CR1","volume-title":"WHO classification of tumours of soft tissue and bone","author":"E de Alava","year":"2020","unstructured":"deAlava E, Lessnick SL, Stamenkovic I (2020) Ewing sarcoma. WHO classification of tumours of soft tissue and bone. 5th ed. IARC Press, Lyon","edition":"5th ed"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-018-0003-x","volume":"4","author":"TGP Gr\u00fcnewald","year":"2018","unstructured":"Gr\u00fcnewald TGP, Cidre-Aranaz F, Surdez D et al (2018) Ewing sarcoma. Nat Rev Dis Primers 4:5","journal-title":"Nat Rev Dis Primers"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00428-010-1023-4","volume":"458","author":"I Machado","year":"2011","unstructured":"Machado I, Noguera R, Mateos EA et al (2011) The many faces of atypical Ewing\u2019s sarcoma. Virch Arch 458:281\u2013290","journal-title":"Virch Arch"},{"key":"5_CR4","doi-asserted-by":"crossref","unstructured":"Llombart-Bosch A, Machado I, Navarro S et al (2009) Histological heterogeneity of Ewing\u2019s sarcoma\/PNET. Virch Arch 455:397\u2013411.","DOI":"10.1007\/s00428-009-0842-7"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1302\/0301-620X.98B8.37346","volume":"98-B","author":"JI Albergo","year":"2016","unstructured":"Albergo JI, Gaston CL, Laitinen M et al (2016) Ewing\u2019s sarcoma: only patients with 100% necrosis after chemotherapy should be classified as good response. Bone Joint J 98-B:1138\u20131144","journal-title":"Bone Joint J"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/modpathol.2016.31","volume":"29","author":"YP Hung","year":"2016","unstructured":"Hung YP, Fletcher CD, Hornick JL (2016) Evaluation of NKX2.2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma. Mod Pathol 29:370\u2013380","journal-title":"Mod Pathol"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/PAS.0b013e31824ee43c","volume":"36","author":"A Yoshida","year":"2012","unstructured":"Yoshida A, Sekine S, Tsuta K et al (2012) NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 36:993\u2013999","journal-title":"Am J Surg Pathol"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/his.13689","volume":"73","author":"S Toki","year":"2018","unstructured":"Toki S, Wakai S, Sekimizu M et al (2018) PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours. Histopathology 73:645\u2013652","journal-title":"Histopathology"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00428-014-1627-1","volume":"465","author":"R Shibuya","year":"2014","unstructured":"Shibuya R, Matsuyama A, Nakamoto M et al (2014) The combination of CD99 and NKX2.2 is highly specific for the diagnosis of Ewing sarcoma. Virch Arch 465:599\u2013605","journal-title":"Virch Arch"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00428-021-03254-8","volume":"480","author":"I Machado","year":"2022","unstructured":"Machado I, Charville GW, Yoshida A et al (2022) Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?. Virch Arch 480:909\u2013917","journal-title":"Virch Arch"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1148\/radiol.2483071742","volume":"248","author":"JS Wu","year":"2008","unstructured":"Wu JS, Goldsmith JD, Horwich PJ et al (2008) Bone and soft-tissue lesions: factors affecting diagnostic yield of image-guided core-needle biopsy. Radiology 248:962\u2013970","journal-title":"Radiology"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00256-006-0244-8","volume":"36","author":"EF Mc Carthy","year":"2007","unstructured":"Mc Carthy EF (2007) CT-guided needle biopsies of bone and soft tissue tumors: a pathologist\u2019s perspective. Skeletal Radiol 36:181\u2013182","journal-title":"Skeletal Radiol"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2106\/JBJS.N.00661","volume":"97","author":"F Traina","year":"2015","unstructured":"Traina F, Errani C, Toscano A et al (2015) Current concepts in the biopsy of musculoskeletal tumors: AAOS exhibit selection. J Bone Joint Surg Am 97:1\u20136","journal-title":"J Bone Joint Surg Am"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"538152","DOI":"10.1155\/2013\/538152","volume":"2013","author":"C Errani","year":"2013","unstructured":"Errani C, Traina F, Perna F et al (2013) Current concepts in the biopsy of musculoskeletal tumors. Sci World J 2013:538152","journal-title":"Sci World J"},{"key":"5_CR15","unstructured":"Laurini J; Antonescu C, Cooper K et al (2017) Protocol for the examination of specimens from patients with primary tumors of bone. CAP https:\/\/www.cap.org\/wp-content\/uploads\/protocols\/cp-other-bone-biopsy-20-4010.pdf (last accessed August 31, 2026)"},{"issue":"1","key":"5_CR16","first-page":"34","volume":"50","author":"I Machado","year":"2017","unstructured":"Machado I, Pozo JJ, Marcilla D et al (2017) Protocol for the study of bone tumours and standardization of pathology reports. Rev Esp Patol 50(1):34\u201344","journal-title":"Rev Esp Patol"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2559.2006.02318.x","volume":"48","author":"DC Mangham","year":"2006","unstructured":"Mangham DC, Williams A, McMullan DJ et al (2006) Ewing\u2019s sarcoma of bone: detection of specific transcripts in FFPE. Histopathology 48:363\u2013376","journal-title":"Histopathology"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-3329-1-6","volume":"1","author":"DC Mangham","year":"2011","unstructured":"Mangham DC, Athanasou NA (2011) Guide-lines for histopathological specimen examination and reporting of primary bone tumors. Clin Sarcoma Res 1:1\u20136","journal-title":"Clin Sarcoma Res"},{"issue":"Suppl 4","key":"5_CR19","first-page":"iv79","volume":"29","author":"ESMO Guidelines Committee, PaedCan","year":"2018","unstructured":"ESMO Guidelines Committee, PaedCan and ERN EURACAN (2018) Bone sarcomas: clinical practice guidelines. Ann Oncol 29(Suppl 4):iv79\u2013iv95","journal-title":"Ann Oncol"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1200\/JCO.2000.18.1.4","volume":"18","author":"G Bacci","year":"2000","unstructured":"Bacci G, Ferrari S, Bertoni F et al (2000) Prognostic factors in nonmetastatic Ewing\u2019s sarcoma of bone treated with adjuvant chemotherapy. J Clin Oncol 18:4\u201311","journal-title":"J Clin Oncol"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejca.2015.09.021","volume":"53","author":"E Wardelmann","year":"2016","unstructured":"Wardelmann E, Haas RL, Bov\u00e9e JV et al (2016) Evaluation of response after neoadjuvant treatment in soft tissue sarcomas (EORTC-STBSG). Eur J Cancer 53:84\u201395","journal-title":"Eur J Cancer"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/01.pas.0000167056.13614.62","volume":"29","author":"AL Folpe","year":"2005","unstructured":"Folpe AL, Goldblum JR, Rubin BP et al (2005) Morphologic and immunophenotypic diversity in Ewing family tumors. Am J Surg Pathol 29:1025\u20131033","journal-title":"Am J Surg Pathol"},{"key":"5_CR23","unstructured":"Brierley JD, Giuliani M, O\u2019Sullivan B, Rous B, Van Eycken E (eds) (2025) TNM classification of malignant tumours. 9th ed."},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1097\/00000478-200012000-00010","volume":"24","author":"AL Folpe","year":"2000","unstructured":"Folpe AL, Hill CE, Parham DM et al (2000) Immunohistochemical detection of FLI-1 protein expression in round cell tumors. Am J Surg Pathol 24:1657\u20131662","journal-title":"Am J Surg Pathol"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.18632\/oncotarget.20098","volume":"9","author":"MC Baldauf","year":"2017","unstructured":"Baldauf MC, Orth MF, Dallmayer M et al (2017) Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets. Oncotarget 9:1587\u20131601","journal-title":"Oncotarget"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"E644","DOI":"10.3390\/cancers12030644","volume":"12","author":"MF Orth","year":"2020","unstructured":"Orth MF, H\u00f6lting TLB, Dallmayer M et al (2020) High specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG positive Ewing sarcoma. Cancers (Basel) 12:E644","journal-title":"Cancers (Basel)"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.prp.2017.08.002","volume":"213","author":"I Machado","year":"2017","unstructured":"Machado I, Yoshida A, L\u00f3pez-Guerrero JA et al (2017) Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in Ewing sarcoma family tumors. Pathol Res Pract 213:1048\u20131053","journal-title":"Pathol Res Pract"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12105-017-0830-1","volume":"12","author":"A McCuiston","year":"2018","unstructured":"McCuiston A, Bishop JA (2018) Usefulness of NKX2.2 IHC for distinguishing Ewing sarcoma. Head Neck Pathol 12:89\u201394","journal-title":"Head Neck Pathol"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41379-018-0095-6","volume":"32","author":"GW Charville","year":"2019","unstructured":"Charville GW, Wang WL, Ingram DR et al (2019) PAX7 expression in sarcomas bearing EWSR1-NFATC2. Mod Pathol 32:154\u2013156","journal-title":"Mod Pathol"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1097\/PAS.0000000000000717","volume":"40","author":"GW Charville","year":"2016","unstructured":"Charville GW, Varma S, Forg\u00f3 E et al (2016) PAX7 expression in rhabdomyosarcoma and related tumors. Am J Surg Pathol 40:1305\u20131315","journal-title":"Am J Surg Pathol"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41379-018-0009-7","volume":"31","author":"MC Baldauf","year":"2018","unstructured":"Baldauf MC, Gerke JS, Orth MF et al (2018) Are EWSR1-NFATc2-positive sarcomas really Ewing sarcomas?. Mod Pathol 31:997\u2013999","journal-title":"Mod Pathol"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/gcc.22336","volume":"55","author":"S Chen","year":"2016","unstructured":"Chen S, Deniz K, Sung YS et al (2016) Ewing sarcoma with ERG gene rearrangements. Genes Chromosomes Cancer 55:340\u2013349","journal-title":"Genes Chromosomes Cancer"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.prp.2014.04.005","volume":"210","author":"I Machado","year":"2014","unstructured":"Machado I, Mayordomo-Aranda E, Scotlandi K et al (2014) Immunoreactivity using anti-ERG monoclonal antibodies in sarcomas is influenced by clone selection. Pathol Res Pract 210:508\u2013513","journal-title":"Pathol Res Pract"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1309\/AJCPN4L1BMRQPEIT","volume":"139","author":"SA Tomlins","year":"2013","unstructured":"Tomlins SA, Palanisamy N, Brenner JC et al (2013) Usefulness of a monoclonal ERG\/FLI1 antibody. Am J Clin Pathol 139:771\u2013779","journal-title":"Am J Clin Pathol"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/his.13252","volume":"71","author":"A Yoshida","year":"2017","unstructured":"Yoshida A, Arai Y, Kobayashi E et al (2017) CIC break-apart FISH misses a subset of CIC-DUX4 sarcomas. Histopathology 71:461\u2013469","journal-title":"Histopathology"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/gcc.22454","volume":"56","author":"YC Kao","year":"2017","unstructured":"Kao YC, Sung YS, Chen CL et al (2017) ETV transcriptional upregulation in diagnosing CIC-rearranged sarcomas. Genes Chromosomes Cancer 56:501\u2013510","journal-title":"Genes Chromosomes Cancer"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/his.13112","volume":"70","author":"SC Smith","year":"2017","unstructured":"Smith SC, Palanisamy N, Martin E et al (2017) Utility of ETV1\/4\/5 RNA in-situ hybridization in CIC-DUX sarcomas. Histopathology 70:657\u2013663","journal-title":"Histopathology"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/modpathol.2016.140","volume":"29","author":"YP Hung","year":"2016","unstructured":"Hung YP, Fletcher CD, Hornick JL (2016) Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas. Mod Pathol 29:1324\u20131334","journal-title":"Mod Pathol"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/modpathol.2016.155","volume":"29","author":"S Le Guellec","year":"2016","unstructured":"Le Guellec S, Velasco V, P\u00e9rot G et al (2016) ETV4 marker in CIC-rearranged undifferentiated round-cell sarcomas. Mod Pathol 29:1523\u20131531","journal-title":"Mod Pathol"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00428-019-02720-8","volume":"476","author":"M Sbaraglia","year":"2020","unstructured":"Sbaraglia M, Righi A, Gambarotti M, Dei Tos AP (2020) Ewing sarcoma and Ewing-like tumors. Virch Arch 476:109\u2013119","journal-title":"Virch Arch"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/PAS.0000000000000965","volume":"42","author":"YC Kao","year":"2018","unstructured":"Kao YC, Owosho AA, Sung YS et al (2018) BCOR-CCNB3 fusion positive sarcomas. Am J Surg Pathol 42:604\u2013615","journal-title":"Am J Surg Pathol"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1200\/JCO.2009.27.2161","volume":"28","author":"FG Barr","year":"2010","unstructured":"Barr FG, Meyer WH (2010) Role of fusion subtype in Ewing sarcoma. J Clin Oncol 28:1973\u20131974","journal-title":"J Clin Oncol"},{"key":"5_CR43","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1200\/JCO.2009.23.3585","volume":"28","author":"MC Le Deley","year":"2010","unstructured":"Le Deley MC, Delattre O, Schaefer KL (2010) Impact of EWS-ETS fusion type on disease progression. J Clin Oncol 28:1982\u20131988","journal-title":"J Clin Oncol"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/gcc.22970","volume":"60","author":"CR Antonescu","year":"2021","unstructured":"Antonescu CR, Rosenberg AE, Xie Z et al (2021) Sarcomas with sclerotic epithelioid phenotype harboring novel EWSR1-SSX1 fusions. Genes Chromosomes Cancer 60:616\u2013622","journal-title":"Genes Chromosomes Cancer"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"e70044","DOI":"10.1002\/gcc.70044","volume":"64","author":"I Machado","year":"2025","unstructured":"Machado I, Llombart-Bosch A, Fumagalli C, Antonescu CR (2025) SSX and SS18-SSX antibodies as tools for EWSR1::SSX3 fusion tumors. Genes Chromosomes Cancer 64:e70044","journal-title":"Genes Chromosomes Cancer"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41379-020-0542-z","volume":"33","author":"R Perret","year":"2020","unstructured":"Perret R, Escuriol J, Velasco V et al (2020) NFATc2-rearranged sarcomas\u2026 AGGRECAN as diagnostic marker. Mod Pathol 33:1930\u20131944","journal-title":"Mod Pathol"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.path.2023.07.001","volume":"17","author":"I Machado","year":"2024","unstructured":"Machado I, Llombart-Bosch A, Charville GW et al (2024) Sarcomas with EWSR1::non-ETS fusion (EWSR1::NFATC2 and EWSR1::PATZ1). Surg Pathol Clin 17:31\u201355","journal-title":"Surg Pathol Clin"},{"issue":"11","key":"5_CR48","doi-asserted-by":"publisher","first-page":"100301","DOI":"10.1016\/j.modpat.2023.100301","volume":"36","author":"KJ Fritchie","year":"2023","unstructured":"Fritchie KJ, Ameline B, Andrei V et al (2023) DNA methylation profiling distinguishes adamantinoma-like Ewing sarcoma. Mod Pathol 36(11):100301","journal-title":"Mod Pathol"},{"issue":"2","key":"5_CR49","doi-asserted-by":"publisher","first-page":"100656","DOI":"10.1016\/j.modpat.2024.100656","volume":"38","author":"CA Dehner","year":"2025","unstructured":"Dehner CA, Warmke LM, Umphress B et al (2025) Superficial neurocristic FET::ETS fusion tumor. Mod Pathol 38(2):100656","journal-title":"Mod Pathol"}],"container-title":["Methods in Molecular Biology","Ewing Sarcoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5587-0_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:54:34Z","timestamp":1792140874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/chapter\/10.1007\/978-1-0716-5587-0_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"ISBN":["9781071655863","9781071655870"],"references-count":49,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5587-0_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"16 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}